Infliximab | Placebo | P | |
---|---|---|---|
N | 5 | 4 | |
Age (years) | 40 ± 2 | 38 ± 3 | nsa |
BMI (kg/m2) | 31.9 ± 0.6 | 31.4 ± 1.1 | ns |
Waist (cm) | 111 ± 4 | 107 ± 7 | ns |
BP syst. (mmHg) | 142 ± 4 | 138 ± 5 | ns |
BP diast. (mmHg) | 94 ± 4 | 87 ± 2 | ns |
FPGb (mmol/L) | 5.7 ± 0.4 | 5.4 ± 0.2 | ns |
Fasting insulin (µU/L) | 15.9 ± 3.5 | 15.2 ± 2.7 | ns |
HOMA index | 4.2 ± 1.2 | 3.7 ± 0.8 | ns |
Cholesterol (mmol/L) | 6.3 ± 0.8 | 6.9 ± 0.9 | ns |
LDL-C (mmol/L) | 2.5 ± 0.4 | 3.4 ± 1 | ns |
HDL-C (mmol/L) | ± 0.1 | ± 0.1 | ns |
Triglycerides (mmol/L) | 5.9 ± 1.8 | 6.0 ± 1.6 | ns |